Skip to main content

and
  1. No Access

    Article

    The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

    Lung cancer is one of the most aggressive tumour types. Targeted therapies stratified by oncogenic drivers have substantially improved therapeutic outcomes in patients with non-small-cell lung cancer (NSCLC)1. Ho...

    Hiroki Izumi, Shingo Matsumoto, Jie Liu, Kosuke Tanaka, Shunta Mori in Nature (2021)